Inside the research
Molina Healthcare, Inc.
MOH Research profile · latest available data
Price overview
$190.86
▼ -2.45 (-1.3%)
| 52w hi | $242.88 |
|---|---|
| 52w lo | $122.65 |
| Vol | 676.40K |
| As of | 25 Sep 2026 |
The Verdict
Our score -0.14
| Short | -0.02 |
|---|---|
| Medium | -0.06 |
| Long | -0.56 |
computed 2026-09-27
Key fundamentals
Molina Healthcare, Inc.
Healthcare · Healthcare Plans
| Market cap | $9.96B |
|---|---|
| Enterprise value | $5.00B |
| Trailing P/E | 1272.40x |
| Forward P/E | 19.59x |
| EV / EBITDA | 12.82x |
| P / S (ttm) | 0.23x |
| Profit margin | -0.0% |
| Return on equity | -0.2% |
| Revenue growth | -5.7% |
| Earnings growth | -75.3% |
| Debt / equity | 94.77 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | -0.10 | |
| Sector | +0.08 | |
| Technical | +0.02 | |
| Earnings | +0.00 | |
| Sentiment | -0.13 |
macro × 1.00 · 2026-09-27
Business overview
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates through Medicaid, Medicare, Marketplace, and Other segments. The company was founded in 1980 and is headquartered in Long Beach, California.
Risk Metrics
| Beta vs SPX | 0.09 |
|---|---|
| Corr SPX | 0.03 |
| Annual vol | 53.1% |
| Annual ret | -15.8% |
| Sharpe | -0.30 |
| Max DD | -65.3% |
Window: 504 trading days (504 obs)
Analyst Coverage
| Mean PT | $180.69 |
|---|---|
| High / Low | $262.00 / $129.00 |
| Median | $169.50 |
| Analysts | 16 |
| Strong Buy | 1 | |
|---|---|---|
| Buy | 3 | |
| Hold | 13 | |
| Sell | 0 | |
| Strong Sell | 1 |
Recent rating actions
| 2026-04-27 | Wells Fargo | → Equal-Weight |
| 2026-04-27 | Truist Securities | → Hold |
| 2026-04-24 | UBS | → Neutral |
| 2026-04-24 | Morgan Stanley | → Equal-Weight |
| 2026-04-24 | Barclays | → Underweight |
| 2026-03-12 | UBS | → Neutral |
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-07-22 | Earnings Release, Exhibits | read |
| 2026-06-10 | Reg FD Disclosure, Exhibits | read |
| 2026-05-11 | Officer / Director Change, Bylaws Amendment… | read |
| 2026-05-08 | Reg FD Disclosure, Exhibits | read |
| 2026-04-22 | Earnings Release, Exhibits | read |
| 2026-02-26 | Reg FD Disclosure | read |
| 2026-02-06 | Material Agreement, Material Obligation… | read |
| 2026-02-05 | Earnings Release, Exhibits | read |
| 2025-11-20 | Material Agreement, Material Obligation… | read |
| 2025-11-18 | Reg FD Disclosure, Exhibits | read |
| 2025-11-17 | Reg FD Disclosure, Exhibits | read |
| 2025-11-14 | Reg FD Disclosure, Exhibits | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | ZORETIC RICHARD C | Grant | 237 | $55.11K | |
| 2026-07-01 | WOLF DALE B | Grant | 237 | $55.11K | |
| 2026-07-01 | Schapiro Richard M | Grant | 237 | $55.11K | |
| 2026-07-01 | ROMNEY RONNA | Grant | 237 | $55.11K | |
| 2026-07-01 | ORLANDO STEVEN J | Grant | 237 | $55.11K | |
| 2026-07-01 | Lockhart Stephen H | Grant | 237 | $55.11K | |
| 2026-07-01 | GROHOWSKI LEO P | Grant | 237 | $55.11K | |
| 2026-07-01 | SOISTMAN FRANCIS S JR | Grant | 237 | $55.11K | |
| 2026-07-01 | BRASIER BARBARA L | Grant | 237 | $55.11K | |
| 2026-06-30 | WOYS JAMES | Chief Operating Officer | Grant | 144 | $21.24K |
Flow & Concentration
| Insider 180d net | $0 |
|---|---|
| Insider buys / sells | 0 / 0 |
| Insider bias | Neutral |
| 13F holders | 9 |
| Top-5 share | 95.0% |
| HHI | 2,700 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| AQR Capital Management | $806.90M | 3.56M |
| Fidelity / FMR LLC | $427.96M | 1.87M |
| State Street Corp | $401.48M | 1.76M |
| Capital Research / Capital World | $142.75M | 624.18K |
| Renaissance Technologies | $72.05M | 315.05K |
| Citadel Advisors | $62.51M | 273.32K |
| Millennium Management | $33.53M | 146.60K |
| Bridgewater Associates | $1.90M | 8.33K |
| T. Rowe Price Group | $285.59K | 1.25M |
As of 2026-06-30
SEC Filings
The Long Run
FY 2012–2025 · 14 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $34.07B | +17.7% | |
| Gross profit | $2.30B | +8.9% | |
| Operating income | $781.00M | +30.7% | |
| Net income | $472.00M | +22.0% | |
| Cash from ops | $644.00M | +4.9% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $193.59 | $195.81 | $189.32 | $190.86 | 676.40K |
| Sep 24 | $190.13 | $194.74 | $188.02 | $193.31 | 559.90K |
| Sep 23 | $190.45 | $191.98 | $185.80 | $189.37 | 647.50K |
| Sep 22 | $199.37 | $199.77 | $190.44 | $191.19 | 525.50K |
| Sep 21 | $201.00 | $202.79 | $197.06 | $197.80 | 640.90K |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →